Mauro Maniscalco
Overview
Explore the profile of Mauro Maniscalco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
174
Citations
1378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Di Stefano A, Gnemmi I, Rosani U, Maniscalco M, DAnna S, Brun P, et al.
Int J Mol Sci
. 2024 Mar;
25(6).
PMID: 38542260
Notch signaling is involved in the prevention of cell differentiation and cell fate in various organs, including the lungs. We aimed to determine the transcriptomic and protein expression of Notch...
22.
Quality of life and work functionality in severe asthma patients: the impact of biological therapies
Leso V, Candia C, Pacella D, Molino A, Nocera C, Maniscalco M, et al.
J Occup Med Toxicol
. 2024 Mar;
19(1):8.
PMID: 38509562
Background: Severe asthma can cause poor health status, poor health-related quality of life (HRQoL) and an impaired functioning at work. However, to date, limited data are available on the impact...
23.
Maniscalco M, Candia C, Calabrese C, DAmato M, Matera M, Molino A, et al.
Respir Med
. 2024 Mar;
225:107578.
PMID: 38431058
Background: In asthma, inflammation affects both the proximal and distal airways and can cause significant hyperinflation, which is thought to be a major cause of dyspnea. Methods: This is a...
24.
Ambrosino P, Marcuccio G, Maniscalco M
Curr Med Chem
. 2024 Jan;
31(37):6013-6017.
PMID: 38204227
No abstract available.
25.
Candia C, Lombardi C, Merola C, Ambrosino P, DAnna S, Vicario A, et al.
J Clin Med
. 2024 Jan;
13(1).
PMID: 38202239
High-flow nasal cannula (HFNC) has recently emerged as a crucial therapeutic strategy for hypoxemic patients both in acute and chronic settings. Indeed, HFNC therapy is able to deliver higher fractions...
26.
Paris D, Palomba L, Albertini M, Tramice A, Motta L, Giammattei E, et al.
Sci Rep
. 2023 Dec;
13(1):22496.
PMID: 38110483
In COVID-19 clinical symptoms can persist even after negativization also in individuals who have had mild or moderate disease. We here investigated the biomarkers that define the post-COVID-19 clinical state...
27.
Maniscalco M, Fuschillo S, Mormile I, Detoraki A, Sarnelli G, De Paulis A, et al.
Cells
. 2023 Nov;
12(21).
PMID: 37947596
Nitric oxide (NO) is a short-lived gas molecule which has been studied for its role as a signaling molecule in the vasculature and later, in a broader view, as a...
28.
Ambrosino P, Marcuccio G, Lombardi C, DAnna S, Sanduzzi Zamparelli S, Mancusi C, et al.
J Clin Med
. 2023 Oct;
12(20).
PMID: 37892629
Background: Alpha-1 antitrypsin deficiency (AATD) can result in severe liver and respiratory disorders. The uninhibited elastase activity on the elastic tissue of arterial walls suggests that AATD may also impact...
29.
Di Stefano A, Rosani U, Levra S, Gnemmi I, Brun P, Maniscalco M, et al.
Biology (Basel)
. 2023 Oct;
12(10).
PMID: 37887014
Background: Bone morphogenic proteins (BMPs) and their antagonists are involved in the tissue development and homeostasis of various organs. Objective: To determine transcriptomic and protein expression of BMPs and their...
30.
Ambrosino P, Motta A, Maniscalco M
Int Forum Allergy Rhinol
. 2023 Oct;
13(12):2266-2267.
PMID: 37846968
No abstract available.